Clinical Trial Update: Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating ABI-007 with carboplatin and gemcitabine for locally advanced bladder cancer; results from the completed study have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• ABI-007 (nab-paclitaxel)
• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-05